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Abstract
E. coli is the most common cause of urinary tract infections (UTIs) in humans 
and is a leading cause of enteric infections and systemic infections. The systemic 
infections include bacteremia, nosocomial pneumonia, cholecystitis, cholangitis, 
peritonitis, cellulitis, osteomyelitis, and infectious arthritis. E. coli is also the lead-
ing cause of neonatal meningitis.
Keywords: bacteremia, septicemia, septic shock, antimicrobial therapy
1. Introduction
Escherichia coli strains compose, physiologically part of the microflora of the 
gastrointestinal tract [1–4]. Belonging to the Enterobacteriaceae family, fermenta-
tive, non-sporulated and facultative anaerobic commensals, they are mainly from 
the large intestine [5, 6].
Despite being commensal microorganisms, they are the Gram-negatives which 
are most often a cause of human infections, having pathogenic strains that cause 
a wide variety of intestinal or extra-intestinal infections, such as urinary tract, 
intra-abdominal and soft tissue, sepsis, neonatal meningitis, gastrointestinal infec-
tion, and pneumonia, often leading to bacteremia [3, 7]. Although Gram-positive 
microorganisms have been increasing as a cause of sepsis due to the instrumentation 
of medical care—understood as the use of invasive devices or tools for the treat-
ment or diagnosis of patients, and to infections associated with health care—E. coli 
continues to be an important and perhaps the most frequent cause of threatening 
infections in our environment [8, 9].
They are classified as Gram-negative bacteria and divided into 3 main groups: 
commensal lines, intestinal pathogenic lines (enteric or diarrhea) and extra-intesti-
nal pathogenic lines [10].
Furthermore, Gram-negative bacteria produce large molecules consisting of a lipid 
and a polysaccharide, known as lipopolysaccharides (LPS), lipoglycans and endotoxin, 
which increases their pathogenicity in relation to Gram-positive bacteria [11].
2. Epidemiology
E. coli is one of the most commonly isolated bacteria in the bloodstream 
(responsible for approximately 20% of all clinically significant isolates) and is the 
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Gram-negative organism most frequently isolated in adult patients with bacteremia 
[12]. In the United States of America, E. coli sepsis was associated with approxi-
mately 40,000 deaths in 2001, a number that corresponds to 17% of all cases of 
sepsis [13].
Studies have shown an increasing incidence of E. coli early-onset sepsis in all age 
groups, overruling group B Streptoccocus for the last 10 years. Beyond that, E. coli 
resistant strains also increased equally in all age groups, with high resistance rates to 
first line antibiotics available (ampicillin and gentamicin).
Very low birth weight newborns remained the group with higher incidence 
(10.4 cases per 1000 live births) and mortality (35.3%). Systematic use of PCR 
increased E. coli early-onset sepsis diagnosis, mainly in the term newborn group. 
There was also an increase in resistant E. coli strains causing early-onset sepsis, 
with especially high resistance to ampicillin and gentamicin (92.8 and 28.6%, 
respectively) [14].
3. Risk factors
Several hospital-based studies have suggested that a number of comorbid 
illnesses, including diabetes, malignancy, chronic lung disease, cirrhosis and 
heart disease, may increase the risk of E. coli bacteremia. Previous researches have 
also identified age (very young and very elder), hospital acquisition, comorbid 
illnesses, presence of shock, non-urinary focus, and antimicrobial resistance in 
conjunction with inadequate treatment as being associated with higher rates of 
death [15–17].
Dialysis, solid organ transplantation and neoplastic disease were important risk 
factors for acquiring E. coli bacteraemia. Ciprofloxacin resistance and non-urinary 
focus were independently associated with an increased risk of death [18]. For 
males, urinary catheterization and incontinence were associated as risk factors to 
Escherichia coli bloodstream, and for females, cancer, renal failure, heart disease 
and urinary incontinence were risk factors reported [19]. Several risk factors 
which have significantly mortality due to E. coli bacteremia are age, severe sepsis 
or shock, non-urinary origin, Charlson index, inadequate empirical treatment 
(Table 1).
4. Pathogenesis
The human gastrointestinal tract is normally inhabited by Escherichia coli, 
which is why they are the bacterial species most commonly found in the isolation 
Mortality risk factor P OR (95% CI)
Age 0.03 1.04 (1–1.08)
Severe sepsis or shock <0.0001 14.64 (6.14–30.86)
Non-urinary origin 0.013 2.78 (1.24–6.2)
Charlson index 0.006 1.31 (1.08–1.59)
Inadequate empirical treatment 0.006 2.98 (1.25–7.11)
Table 1. 
Results of multivariate analyses examining risk factors for mortality associated with bacteraemia due to 
E. coli [15].
Pleas  use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Co nect on...Ac obat is ocki g documen loading.com
r
File cannot be found.
3Management of E. coli Sepsis
DOI: http://dx.doi.org/10.5772/intechopen.93132
of fecal culture [20, 21]. By the time the strains acquire additional genetic 
material, they can become pathogenic and circulate widely throughout the body. 
Pathological clones are divided into two major groups: intestinal (among the 
most virulent enteric pathogens) and extraintestinal (less present, but not less 
dangerous) [22, 23].
4.1 Intestinal
4.1.1 EPEC
Typical enteropathogenic Escherichia coli (tEPEC) contains a virulence plas-
mid (pEAF) that encodes the bundle-forming pilus (BFP), the primary factor 
for colonization [24, 25]. In addition, EPEC carries the crossomic island of locus 
for enterocyte effacement, which features the eae gene, which is the encoder of a 
colonization factor in the outer membrane protein called intimin [26, 27]. Only the 
E. coli strain that has pEAF and the eae gene can be considered tEPEC, one that has 
only the eae gene and is called atypical EPEC (aETEC) [28].
The small intestine is the most likely place for EPEC infection to occur. For the 
onset of diseases, tEPEC obeys the following steps:
• Initial localized adhesion of organisms to enterocyte via BFP.
• Induction of signal transduction in the enterocyte by secretion of protein 
toxins.
• Development of intimin-mediated intimate adhesion to the enterocyte.
Around 20 protein toxins are injected directly into the target epithelial cell, 
made, together with the intimin, by the chromosomal island LEE and expressed by 
both tEPEC and aEPEC [29]. The complex nanomachine called type III secretion 
injector is the one that injects protein toxins. It is assumed that some modifications 
happen to the epithelial stem cells, which is physiologically absorbent, and through 
a pathological process, it becomes a secretory dynamo [30].
What is believed is that type III ejection toxins are responsible for binding to 
protein elements of the cell’s signal transduction apparatus. This event is accompa-
nied by the mobilization of calcium from the intracellular compartment, activation 
of protein kinase C, kinase light chain myosin and induction of protein phos-
phorylation by tyrosine. The rearrangement of cytoskeletal proteins is induced by 
effectors, which results in the classic lesion "attaching and erasing," changes in the 
secretion of water and electrolytes and increased permeability of the tight intestinal 
junctions [31].
4.1.2 ETEC
Enterotoxigenic Escherichia coli (ETEC) consists of ingestion of bacteria, 
intestinal colonization and production of virulence factors. Colonizing fimbriae 
(CFs) must be expressed by ETEC to allow the consolidation of the bacteria in the 
intestine [32].
After colonization, ETEC produces two classes of secretory toxins encoded 
by plasmids: heat-labile toxin (LT) and heat-stable toxin (ST). To be classified as 
ETEC, E. coli must contain one or both classes of toxins [33, 34].
LT toxin is related to Vibrio cholera toxins in terms of structure, function and 
mechanism. It works by stimulating adenylate cyclase and increasing adenosine 
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intracellular cyclic monophosphate (AMP), a fact that stimulates chloride secre-
tion from intestinal crypt cells and inhibits the absorption of sodium chloride at 
the ends of the villi. After that, the water secretion is free in the intestinal lumen, 
clinically developing watery diarrhea [35].
STa toxin, the only ST variant that causes disease in humans, activates cyclic 
GMP of enterocytes, leading to increased chloride secretion and decreased sodium 
chloride absorption. As a final result, the secretion of free water in the intestinal 
lumen clinically appears as watery diarrhea [36].
4.1.3 EHEC
Among the pathotypes that cause the most severe conditions, the strains classi-
fied as enterohemorrhagic (EHEC) stand out, which are the most common to cause 
disease in developed countries [29].
They are bacteria responsible for food infections and represent a risk to the 
health of the population, so they must be monitored frequently. Thus, good hygiene 
practices, as well as the use of quality tools, are extremely important to help reduce 
the risk of cross-contamination and human infection.
EHEC has the ability to attach itself to the host and to produce shiga-toxins, 
which gives the strain pathogenicity. The toxins produced by EHEC cause damage to 
the mucosa of the large intestine, where they are absorbed by reaching the blood-
stream, which makes it possible to affect other organs, such as the kidneys [37]. An 
average of 5–10% of patients confirmed with EHEC infection develop potentially 
fatal complications, such as hemolytic uremic syndrome (HUS), which leads to 
sudden renal failure and hemolytic anemia [38].
Outbreaks are related to the ingestion of contaminated food and water, causing 
watery diarrhea and hemorrhagic colitis to those infected. The disease has a sudden 
onset with severe abdominal cramps and watery diarrhea that progresses to bloody, 
on average after 24 hours, lasting between 1 to 8 days.
The treatment consists of supportive therapy for fluid replacement, since the 
use of antibiotics is not indicated, as there is no proven efficacy. In fact, it could 
increase the risk of developing HUS, since the death of the bacteria would increase 
the release of toxins, predisposing to the syndrome [39].
4.1.4 EIEC
Enteroinvasive E. coli (EIEC) is very close to Shigella and develops a colitis 
similar to shigellosis. The intestinal cell is invaded by the EIEC which multiplies 
intracellularly and reaches the adjacent intestinal cells [40].
To differentiate Shigella from EIEC it is necessary to analyze the strains, those 
from EIEC ferment glucose and xylose, this differentiates them. Nucleic acid tests, 
including multiplexed panels, are used to detect organisms [41].
4.1.5 DAEC
Diffusely adherent E. coli is associated with diarrhea, which is characterized 
as watery and can become persistent in children between 1 and 5 years of age, 
occurring more frequently in developing and developed countries. In addition, this 
bacterium is also related to urinary tract infections and complications during the 
pregnancy period.
The pattern of diffuse adhesion in HEp-2 or HeLa cells is a characteristic that 
differentiates this pathotype from the others, although DAEC strains are quite 
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heterogeneous. This adhesion is mediated by fimbrial and afimbrial adhesins, which 
can cause damage to microvilli due to the disorganization of the cytoskeleton. 
However, some strains produce an adhesin involved in diffuse adhesion (AIDA-I), 
instead of encoding the diffuse adhesion pattern, which is why they are called 
atypical DAEC [42].
In addition, DAEC can also provide a pro-inflammatory effect [43].
4.2 Extraintestinal
The type of E. coli responsible for the invasion, colonization and induction 
of diseases in body sites outside the gastrointestinal tract is the extraintestinal 
pathogenic Escherichia coli (ExPEC). It is noteworthy that diseases caused by ExPEC 
range from urinary tract infections, neonatal meningitis, sepsis, pneumonia, surgi-
cal site infections to infections in other extraintestinal sites, representing a burden 
in terms of medical costs and lost productivity [44].
Thereto, the ExPEC strains were isolated from food products, in particular raw 
meat and poultry, indicating that these organisms potentially represent a new class 
of foodborne pathogens [45].
4.2.1 Urosepsis
Almost 25% of sepsis cases originate from the urogenital tract. [46–48]. 
Considering this percentage, the most common pathogen that causes urinary tract 
infection (and, consequently, urosepsis) is Escherichia coli (50%) [49]. It is known 
that this condition is better managed with an interprofessional team of health 
professionals—a nephrologist, infectious disease expert, urologist, intensivist, a 
nurse and a pharmacist [50, 51]. The outcomes after urosepsis depend on the cause 
and severity of the infection, and if the patient has a complicating factor in the 
urinary tract that is identified and warrants treatment, it should be performed as 
soon as possible. As an example, the literature reveals Foley catheter placement to 
relieve urinary retention or stent placement to bypass an obstructing ureteral calcu-
lus causing urosepsis. Moreover, the prognosis also depends on the type of bacteria, 
antimicrobial resistance, and patient comorbidity.
In addition to early antibiotics, there are some important parts of the manage-
ment of sepsis. Initial fluid resuscitation with crystalloid is still recommended at 
a minimum of 30 mL/kg. Consider early administration of vasopressor support 
to maintain a mean arterial pressure greater than 65 mm Hg. The first choice for 
vasopressor support in sepsis is norepinephrine (with epinephrine and vasopressin 
2 and 3). Tight glucose control is also recommended, with corticosteroids and blood 
products being more controversial in the literature [52].
5. Antimicrobial resistance
Although Escherichia coli is one of the most-studied microorganisms worldwide, 
its characteristics are constantly changing. Elseways, one important global problem 
is the increase of antimicrobial resistance shown by bacteria, being considered as 
“threatens the achievements of modern medicine” [53, 54].
E. coli resistant strains increased equally in all age groups, with high resistance 
rates to our first line antibiotics (ampicillin and gentamicin), with relevant high-
light in neonatal E. coli isolates from invasive infection [55]. Table 2 shows the 
temporal trends for antibiotic resistance to E. coli.
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Agent or phenotype 
[n (%)]
1997 
n = 58
1998 
n = 49
1999 
n = 52
2000 
n = 83
2001 
n = 86
2002 
n = 70
2003 
n = 87
2004 
n = 122
2005 (January–
June) n = 56
Total 
n = 663
P
Ampicillin 27 (46.6) 24 (49) 24 (46.2) 50 (60.2) 54 (62.8) 46 (65.7) 55 (63.2) 70 (57.9) 35 (62.5) 385 (58.2) 0.02
Trimethoprim/
sulfamethoxazole
14 (24.1) 11 (22.4) 13 (25.0) 28 (33.7) 21 (24.4) 28 (40) 32 (36.8) 41 (33.6) 20 (35.7) 208 (31.4) 0.02
Ciprofloxacin 9 (15.5) 7 (14.3) 10 (19.2) 7 (8.4) 14 (16.3) 16 (22.9) 22 (25.3) 27 (22.1) 13 (23.2) 125 (18.9) 0.02
Amoxicillin/
clavulanate
9 (15.5) 4 (8.2) 9 (17.3) 16 (19.3) 8 (9.3) 7 (10) 11 (12.6) 15 (12.3) 20 (35.7) 99 (14.9) 0.1
Gentamicin 4 (6.9) 6 (12.2) 5 (9.6) 5 (6.0) 8 (9.3) 6 (8.6) 7 (8.0) 8 (6.6) 8 (14.3) 57 (8.6) 0.8
Piperacillin/
tazobactam
1 (1.7) 4 (8.2) 1 (1.9) 8 (9.6) 6 (7.0) 4 (5.7) 5 (5.7) 2 (1.6) 2 (3.6) 33 (5) 0.4
Cefotaxime 11 2 (4.1) 0 2 (2.4) 3 (3.5) 5 (7.1) 3 (3.4) 12 (9.8) 4 (7.1) 31 (4.7) 0.001
ESBL production 0 0 0 2 (2.4) 3 (3.5) 3 (4.3) 2 (2.3) 9 (7.4) 3 (5.4) 22 (3.3) 0.002
MDR 4 (6.9) 4 (8.2) 5 (9.6) 9 (10.8) 9 (10.5) 12 (17.1) 15 (17.2) 17 (13.9) 12 (21.4) 87 (13.1) 0.006
Table 2. 
Number, yearly percentages, and P values for temporal trend of non-susceptible cases of E. coli bacteraemia.
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6. Evaluation
The sepsis’ diagnosis confirmation is done from the evaluation of the clinical 
status of the patient, analyzing some criteria. For adult patients, it is confirmed or 
a diagnosis of sepsis is made when two criteria are present: hyperthermia>38.3 °C 
or hypothermia <36°C, tachycardia>90 bpm, leukocytosis (>12,000 μL-1) or 
leukopenia (<4000 μL-1) or >10% bands, acutely altered mental status, tachypnea 
> 20 bpm, hyperglycemia (>120 mg/dl) in the absence of diabetes [56].
7. Clinical assessment and patient presentations
7.1 History and physical examination
Collect a careful history from patient, addressing information such as previous 
illnesses, surgeries, how long ago the symptoms started, if there are comorbidi-
ties, if it have traveled to a place recently and other details, added to a complete 
physical examination, which provides very relevant information and leads to a line 
of rationality, it is extremely important to start the development of a preliminary 
differential diagnosis of the patient’s complaints.
All this information collected is recorded and saved in medical records, more 
recently, electronics, which are more organized, more readable and allows a better 
comparison, in relation to written records [57].
Some of the most frequent reasons that lead patients to go to a medical con-
sultation are dyspnea, cough with or without hemoptysis and chest pain, as these 
symptoms can be indications of serious illnesses, it shows the importance of asking 
questions and exams in a way attentive and careful [58].
7.2 Presentations
7.2.1 Pneumonia
Ventilator-associated pneumonia (VAP) is the most common fatal hospital 
infection [59]. One of the bacteria most involved in the clinical picture in question 
is Enterobacteriaceae Escherichia coli [60, 61] and there is little awareness when it 
comes to the pathophysiology of E. coli pneumonia.
Studies show that these E. coli pathogenic islands (PAIs) are involved differently 
in the pathogenicity of the lung compared to those present in urinary tract and 
bloodstream infections [62]. In addition, research on mice has also shown that these 
isolated strains are highly virulent extra-intestinal pathogens that express virulence 
factors, representing potential targets for new therapy. A French national study also 
demonstrated that, despite the genomic and phylogenetic characteristics of E. coli 
pneumonia isolates from critically ill patients, they belong to the same extra-intesti-
nal pathogen as E. coli, they have specific distinct characteristics when lungs [63].
7.2.2 Acute-bacterial meningitis
E. coli meningitis is rare in adult forms of the disease [64–66], but it is a frequent 
pathogen in the pediatric field [67]. Despite its rarity, it has a serious clinical course 
[64–66]. It is usually diagnosed based on clinical signs and cerebrospinal fluid 
(CSF) analysis.
Due to the severity of the disease, early diagnosis, adequate antibiotic treatment 
and hemodynamic control are essential [68].
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E. coli meningitis follows a high degree of bacteraemia and invasion of the 
blood–brain barrier. With mortality rates ranging from 15 to 40%, Meningitis due to 
this bacterium leaves approximately 50% of survivors with some type of neurologi-
cal sequelae [69–78].
Although the process is unknown, it is known that, for the onset of the disease, 
it is necessary to have an invasion of the blood–brain barrier by E. coli, which 
requires specific microbial and host factors such as specific signaling molecules for 
microbes and hosts. Thus, blocking these microbial and host factors that contribute 
to the invasion of the blood–brain barrier by E. coli is effective in preventing the 
penetration of E. coli into the brain.
With the complete discovery of this mechanism, it is likely that new targets for 
the prevention and therapy of Escherichia coli meningitis will be achieved [79].
Regarding treatment, it is currently known only that antimicrobial chemo-
therapy has limited efficacy [79–81].
7.2.3 Intra-abdominal infections
Intra-abdominal infections (IAI) are invasive and bacterial multiplications in 
the hollow organ walls and beyond. Usually, it is located in the abdominal cavity, in 
the retroperitoneum and in the abdominal organs, being a common complication 
in the post-surgical period [82]. In addition, they have a wide variety of pathologi-
cal conditions, from appendicitis to fecal peritonitis, which makes IAI generally 
have a poor prognosis (especially in high-risk patients) and is an important 
cause of morbidity [83]. Mostly, the most common source of this infection is the 
appendix, followed by gastroduodenal perforations. The Gram-negative bacteria 
E. coli is the most common causative agent of IAI. Therefore, it is important to 
know that they have great sensitivity to imipenem, meropenem, mainly, and to 
amoxi-clavulanate, amikacin and piperacillin-tazobactam, next [84, 85]. However, 
amici-clavulanate is prescribed as a first-line drug in developing countries, due to 
cost factors [86].
7.2.4 Enteric infections
Although E. coli strains have been isolated as part of the normal beneficial flora 
of the intestine, some strains have developed pathogenic mechanisms to cause 
disease in humans and animals. One of these strains capable of causing diseases is 
enteric Escherichia coli (E. coli), comprising important pathogens, since they cause 
significant morbidity and mortality worldwide. Traditionally enteric E. coli was 
divided into 6 pathotypes, however two other divisions were proposed by several 
studies (as mentioned individually in topic 4) [87].
Although there are many etiological agents responsible for diarrhea, pathogenic 
E. coli is a major contributor. On the other hand, the onset and complications of 
enteric E. coli vary significantly, despite there are many common features  
in the pathogenic process of colonizing the intestinal mucosa and the onset of 
disease [88].
Outbreaks are common all over the world, with fatal consequences mainly in 
children under 5 years of age living in underdeveloped countries, where diarrheal 
diseases can lead to death more frequently [89].
The transmission of enteric E. coli is also a public health concern, related to the 
development of countries, since its transmission is through contaminated water and 
food. Thus, the seriousness in relation to the microorganism can be exemplified by 
national and international surveillance programs, created by developed countries 
that aim to constantly monitor outbreaks [90]. In developing countries ETEC, 
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EPEC and EAEC are considered to be the main causes of childhood diarrhea, and 
when left untreated, they have potentially fatal consequences. However. in devel-
oped countries, these infections are mild and self-limiting, with EHEC and, more 
recently, EAEC and STEAEC being the main E. coli pathotypes associated with food 
poisoning outbreaks [91, 92].
7.2.5 UTI
Among the most common types of bacterial infections that occur both in the 
community and in hospitals, urinary tract infections (UTI) stand out. Urinary 
tract infections can be associated with the hospital (HAUTIs) and the community 
(CAUTIs). In the case of CAUTIs, it is known whether women are the predominant 
group of patients.
Although the UTI is multifactorial, the main bacteria related to the diagnosis is 
E. coli, predominant in both community and nosocomial UTIs [93].
Co-trimoxazole (trimethoprim/sulfamethoxazole), nitrofurantoin, ciprofloxa-
cin and ampicillin are the antibiotics commonly recommended for the treatment of 
UTIs. However, there is an overall increase in antibiotic resistance among pathogens 
in the urinary tract, which is a limitation on treatment options [94, 95].
Since the evidence suggests a significant relationship between the extensive 
use of antibiotics and antimicrobial resistance, it is necessary to prescribe and use 
antibiotics in order to reduce their complications and costs [96].
For this reason, in order to guide the selection of empirical therapy, surveil-
lance of antibiotic resistance is crucial for determining the pattern of antimicrobial 
resistance [97].
8. Workup
8.1 Urine culture
It aims to check the presence of fungi and bacteria in the urine, being carried out 
from a urine sample, which was placed in Petri dishes. The urine culture is placed 
in an incubator (1–2 days) and if there is any microorganism in the tested mate-
rial, colonies grow and are visible on the plate. When the result is positive for some 
bacteria, a test antibiogram is performed, which determines the type of antibiotic 
needed to act against the pathogen [98].
The culture of urine is important precisely because it allows the precise recogni-
tion of the bacteria and, consequently, the best antibiotic to be used [99].
As urine culture is most frequently requested when UTI is suspected, the most 
common bacteria found are Escherichia coli (between 47.5% and 56.4% of all urine 
culture) [100, 101].
8.2 Blood culture
Blood culture is part of the routine assessment of patients with suspected blood-
stream infection, and is crucial to guide therapeutic intervention. The ideal method 
for collecting blood culture is venepuncture, since it increases diagnostic yield, and 
has lower rates of contamination, according to some studies [102].
Since the timing of blood culture collection does not influence the detection of 
clinically relevant microorganisms, most authorities recommend collecting several 
sets simultaneously or for a short period of time, with the exception of patients with 
endovascular infection who need documented continuous bacteremia [103, 104].
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Two to four sets of blood samples should be collected, whenever possible, at 
independent locations [103–106]. For adults, the volume required for the exami-
nation varies between 40 and 160 mL of blood, and for babies and children, the 
volume is age-based and does not exceed 1% of the patient’s total blood volume 
[103, 107].
The importance of blood culture, as well as urine, is related to the determination 
of the bacteria and the antibiogram, which directs the treatment to the best antibi-
otic to be used [108].
8.3 Localization of underlying abnormality
In some cases, it is possible to suspect a complicated urinary tract infection/
urosepsis without being serious urological abnormalities. In such cases, there are 
some screening options that can be performed to assist in the management of the 
patient. Thus, simple abdominal radiography, intravenous urography, ultrasound, 
computed tomography and magnetic resonance imaging are cited [109].
8.4 Imaging exams
The anatomical identification of most areas of infection has become common 
with the development of high resolution cross-sectional images, which allow 
visualization of bacterial and viral metabolism, early diagnosis and treatment. 
Thus, the cross-sectional image was included as part of the routine investigation of 
unidentified infection sites and sources of sepsis. The trend is that the use of these 
images will become increasingly widespread and become part of standard clinical 
care in the near future [110].
8.4.1 Ultrasonography
When abdominal sepsis is suspected, ultrasound is a valuable tool. As it is a 
portable scanning technique, it is ideal for clinically unstable patients who cannot 
be transported to an examination room [110].
Ideal for the diagnosis of liver sepsis and gallbladder, ultrasound identifies and 
indicates the presence and location of intra-abdominal fluids (subphrenic space, in 
pericological calculations or pelvis) [110–113]. Intrahepatic fluids are also well visu-
alized, and can even be drained percutaneously with ultrasound guidance [110].
The main obstacle for ultrasound responses is air interference, highlighted 
in loop regions of the intestine with intraluminal gas, since the USG image is 
darkened and makes it difficult to visualize interloop abscesses or peri-pancre-
atic collections. The intestine in patients with disease due to sepsis or recent 
intra-abdominal surgery is also capable of compromising the quality of the 
ultrasound [114].
8.4.2 CT scanning
The availability of CT scanners with multiple detectors allows rapid acquisition 
of images, making this method the most common in the diagnosis and detection of 
intra-abdominal abscesses [114, 115]. It is an interesting option especially for sick 
patients who have difficulty holding their breath, obese or with abdominal or chest 
bandages.
In addition, CT is essential in the diagnosis of interloop and retroperitoneal 
pathologies (including retroperitoneal abscesses or pancreatitis or intra-biliary 
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stones), in addition to being highly sensitive in the detection of chest patholo-
gies (pneumonia, pleural effusion and localized collections) [113, 115–117]. For 
intra-abdominal fluids and abscesses, CT showed a sensitivity of 90–100%, while 
ultrasound showed sensitivity between 80% and 85% [115, 118, 119].
Due to the contemporary contrast protocols available, it is possible to identify by 
CT even small infected collections [110].
8.4.3 Hybrid PET/MRI systems
With the development of hybrid cameras, the combination of PET and magnetic 
resonance imaging was introduced, which despite having interesting advantages 
and clinical applications, is still such an expensive tool.
The simultaneous acquisition of PET and magnetic resonance imaging can pro-
vide quantitative molecular functional information about the inflammatory lesion 
and precise location, in addition to anatomical changes with movement correction, 
improving the differential diagnosis and guiding anti-inflammatory treatment 
strategies.
Since MRI cannot visualize all parts of the body at once, the new hybrid tech-
nique may require collaboration between radiologists and nuclear medicine doctors 
to interpret the image and can be more expensive than PET/CT (capital and opera-
tional costs).
The functional image of inflammation and infection was mainly restricted to the 
flat image and SPECT, however, with the increasing development of PET radiophar-
maceuticals, the detection and quantification of specific aspects of inflammatory 
processes became more sensitive. Precisely for this reason, there is an interesting 
potential in the application of hybrid whole body PET/MRI in the context of the 
investigation of infectious and inflammatory diseases [120].
8.5 Biologic scanning
Imaging technique that uses biological radionuclides to track hidden infections 
and improve the specificity of the infection diagnosis that allows the detection 
of early pathophysiological changes even when there are no apparent anatomical 
changes. When compared to ex vivo techniques (blood culture), in vivo biological 
screening is preferred since it is accurate, does not require a sterile environment 
and does not expose the health team to the risk of contamination by blood-borne 
pathogens.
This type of tool is used mainly in patients suspected of infection or abscess, 
but who have had negative results for the cross-sectional image. Thus, the use of 
marked leukocyte traffic allows a response to hidden sites, based on the recognition 
of white blood cells marked with radionuclides. The marked leukocytes travel to the 
infection sites and allow noninvasive images in areas of hidden infection, such as 
osteomyelitis, orthopedic prosthesis, endocarditis or inflammation and intestinal 
disease [110].
9. General management of sepsis and septic shock
9.1 Hemodynamic support
Adequate organ perfusion must be ensured. Hypotension should be managed 
initially with intravenous fluid administration and the goal should be maintenance 
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of pulmonary capillary wedge pressure at 12–16 mm Hg or central venous pressure 
at 8–12 cm H2O. Urine output rate should be kept at greater than 0.5 mL/kg/hr. 
A mean arterial blood pressure of greater than 65 mmHg (systolic blood pressure 
greater than 90 mmHg) and a cardiac index of greater than or equal to 4 L/min/
m2 should be maintained. Vasopressor therapy should be initiated in the event of 
failure to achieve these goals with iv fluids alone. These include dopamine, dobuta-
mine and norepinephrine [109].
9.2 Respiratory support
Ventilatory support should be provided for patients with progressive hypox-
emia, hypercapnia, altered sensorium or respiratory muscle fatigue. A study of 
“early goal directed therapy” (EGDT) found that prompt resuscitation to maintain 
SvO2 > 70% was associated with improved survival in patients of severe sepsis 
[121]. In this study, failure to maintain saturation after fluids and vasopressors was 
followed by erythrocyte infusion to raise hematocrit to 30%. Patients requiring 
mechanical ventilation should be adequately sedated and stress ulcer prophylaxis 
should be administered.
9.3 Metabolic support
Blood glucose levels should be maintained at less than 150 mg/dL during initial 
few days of severe sepsis and normoglycemic range could be targeted later. Frequent 
blood glucose monitoring should be done to avoid hypoglycemia in patients on 
intensive insulin therapy. Multi-organ dysfunction, if any should be managed. 
Disseminated intravascular coagulation, if accompanied by major bleeding, should 
be treated with fresh-frozen plasma and platelet transfusion. Hypercatabolic 
individuals with acute renal failure benefit substantially from hemodialysis or 
hemofiltration. Prophylaxis for deep vein thrombosis and nutritional supplementa-
tion should be undertaken [109].
10. Treatment of carbapenem-resistant Enterobacteriaceae
10.1 Monotherapy vs. combination therapy for treatment
Considering the limited knowledge about the combination of antibiotics, the 
susceptibility of these pathogens to drugs and the lack of evidence to support the 
routine use of combined antimicrobial therapy, the decision regarding the ideal 
therapy is the responsibility of medical professionals [122]. Regarding the most 
appropriate approach, it is prioritized in the literature that the optimization of 
antimicrobial therapy includes adaptation of the appropriate antibiotics in terms of 
class, dose, frequency, route and duration [123].
The combination of different antibiotics has been widely used by large 
centers when it comes to invasive infections by multi-resistant Gram-negative 
bacteria [122].
10.1.1 Positive and negative aspects of combination therapy for treatment
The various positive and negative aspects of combination therapy are depicted 
in Table 3.
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10.2 Colistin
Antibiotics such as colistin are the last resort to deal with infections by 
carbapenem-resistant Enterobacteriaceae (CREB), and when the pathogen does not 
respond to colistin, therapeutic options are severely restricted. Thus, it becomes 
necessary to restore the sensitivity of the pathogen to the drug [125].
The combination of colistin + salicylate + potent efflux pump inhibitor (BC1) has 
been documented with highly positive results, providing a connection between colis-
tin and the efflux pump inhibitor (BC1), which prevents extrusion of colistin [126].
The reduction in affinity between the drug and Gram-negative bacteria is due 
to the modification of lipid A, linked to the appearance of the gene that confers 
resistance to bacteria, which is present in animals that receive colistin and are part 
of human food. Despite this, there is still no complete explanation of the mutation 
and resistance of Gram-negative bacteria (especially Enterobacteriaceae) in patients 
who received administered colistin [127].
10.3 Carbapenems
Due to the increased resistance of bacteria to cephalosporin (and aminopeni-
cillins), the use of narrow-spectrum β-lactamases, especially carbapenems, has 
increased considerably, being the only β-lactamase antibiotics with proven effec-
tiveness in serious infections due to ESBL-producing bacteria [128–130].
With the discovery of E. coli isolates capable of producing new b-lactamases, 
a new strain of E. coli was found capable of resisting the action of carbapenems, 
mediated by plasmids.
These enzymes are able to confer resistance to drugs of the class b-lactamases, 
and in relation to E. coli specifically, the main types of enzymes are CMY, CTX-M 
and NDM of b-lactamase [131].
10.4 Tigecycline and other tetracyclines
Tigecycline is a new expanded-spectrum antimicrobial agent in the glycylcycline 
class. Developed with the objective of overcoming the most common processes 
of bacterial resistance, the drug has emerged as a great therapeutic option in the 
Positive aspects of combination therapy for 
treatment
Negative aspects of combination therapy for 
treatment
1. Greater probability of choosing an effective 
agent and well-founded theoretical reasons to 
support its use
2. Considering the increase in mortality related to 
the delay in the establishment of treatment and 
delays in appropriate and effective antimicrobial 
treatment, it is prudent to initiate empirical 
broad-spectrum antimicrobial treatment in the 
first suspected infection in critically ill patients
3. Indicated for patients with compromised 
immune systems, previous ICU admissions or 
who have recently received broad-spectrum 
antibiotics [124]
1. Increased toxicity in treatment by combining 
antibiotics (nephrotoxicity and ototoxicity). In such 
cases, it is suggested to discontinue the old therapy and 
introduce a new one, based on the clinical evolution 
of the patient and the results of the culture and 
susceptibility profile
2. This type of therapy has not been shown to be 
effective by clinical data (meta-analyses performed 
with the evaluation of randomized clinical trials 
demonstrate that there was no difference in clinical 
results between the two strategies for definitive 
treatment of Gram-negative bacteria infections) [124]
Table 3. 
Comparison of positive and negative aspects of combination therapy.
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treatment of serious infections, which endanger the patient’s life, and which no 
longer respond to traditional antibiotics. The use of tigecycline is mainly interest-
ing for the initial therapy of major infections, and is largely effective in the action 
against multi-resistant Gram-negative bacteria [132].
10.5 Aminoglycosides
Aminoglycosides are natural or semi-synthetic drugs obtained from actino-
mycetes, used as an antibiotic since the beginning of bacterial treatment. As it 
was replaced in the 1980s by cephalosporins, carbapenems and fluoroquinolones, 
aminoglycosides had little use.
With the increase in the number of cases of multidrug-resistant bacteria, amino-
glycosides were again considered for their ability to synergize with a variety of other 
classes of antibacterials, improving the safety and effectiveness of the class through 
optimized dosing regimens, being broad-spectrum and quickly bactericidal.
Enzymatic modification by acetylation of an amino group, impaired uptake and 
phosphorylation of aminoglycosides are the most commonly reported processes 
that confer resistance to bacteria in relation to aminoglycosides [133].
10.6 Fosfomycin
Fosfomycin is an antibiotic from the 1969s, prescribed mainly in its oral form for the 
treatment of uncomplicated urinary tract infections (UTI), and considered as an option 
in the treatment of bacteria with advanced resistance, causing serious infections [134].
For E. coli NDM-producing strains, fosfomycin, colistin and tigecycline are more 
effective than other antibiotics [135].
The best pharmacological approach to E. coli infections resistant to carbapenems 
is still an obstacle to be overcome, since patients infected with this type of bacteria 
have more limited clinical results and when compared to patients infected with 
bacteria susceptible to drugs [136].
10.7 Duration of therapy
The duration of treatment for infection caused by Escherichia coli varies in the 
literature, but most patients require treatment for about 14–21 days [109]. For E. coli 
perinephric abscesses or prostatitis, it is recommended that the minimum antibiotic 
use time should be 6 weeks, intra-abdominal infections 14–21 days, and pneumonia 
14 days (Table 4) [137].
11. Special considerations
11.1 Urinary infections in diabetes mellitus
In general, infectious diseases occur more frequently and cause greater concern 
when dealing with diabetic patients. This occurs because the environment offered 
Condition General Perinephric 
abscesses
Prostatitis Intra-abdominal 
infections
Pneumonia
Duration 14–21 days 42 days 42 days 14–21 days 14 days
Table 4. 
Recommended duration of antibiotic therapy depending upon the type of infection.
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by the organism is rich in glucose, which favors immune dysfunction, including 
decreasing the antibacterial activity of the urine and its motility [138].
Moreover, when comparing E. coli isolated in the urine of diabetics and non-
diabetics, the same virulence factors and the same resistance to antimicrobials are 
found, inferring that there is no difference in the causative bacteria. This way, what 
makes the prevalence of urinary infections to be higher in diabetic patients is the 
greater adhesion of E. coli bacteria to diabetic uroepithelial cells, the reduction of 
urinary cytokine secretion and the number of leukocytes [139].
Hence, to treat the disease, the most commonly prescribed antimicrobials are 
used—amoxicillin, nitrofurantoin, trimethoprim/sulfamethoxazole (TMP/SMX) 
and ciprofloxacin. It is understood that the same treatment choice used by nondia-
betic patients can be made, depending only on the local resistance patterns of the 
commonly found uropathogens [140, 141].
Generally, most uropathogens have a high resistance to TMP/SMX, in addition, 
this antimicrobial can cause hypoglycemia, which makes it not a good first choice of 
treatment for this portion of patients [142].
As for the treatment, it is recommended to consider the urinary tract infection 
complicated, it is advisable to keep the treatment for a period of 7 to 14 days [143].
11.2 Acute pyelonephritis
Acute pyelonephritis is an infection located in the upper urinary tract, which 
accommodates either parenchyma and renal pelvis, with Escherichia coli being the 
most common etiological agent [144, 145].
Approximately 250,000 cases of this disease are reported each year, with more 
than 100,000 eventually requiring hospitalization [146].
In order to confirm the diagnosis of the disease, the patient’s urine culture is per-
formed before the start of antibiotic therapy [147]. In addition, it is recommended 
to perform a microbial susceptibility test in order to select the most appropriate 
antimicrobial regimen [148, 149].
If the diagnosis is uncertain or the patient is immunocompromised and suspected 
of having a hematogenic infection, blood culture analysis is requested [150, 151].
In the last few decades, there has been an increasing rate of resistance of E. coli 
bacteria to beta-lactam antibiotics of extended spectrum [152]. Thus, for patients 
with mild and uncomplicated acute pyelonephritis, fluoroquinolone is a good 
choice for initial outpatient antibiotic therapy, if the drug resistance rate is 10% or 
less in the community [153].
On the other hand, in cases of complicated infections, sepsis or failed outpatient 
treatment, hospital treatment is best indicated [154]. After antibiotic therapy, urine 
culture should be performed again after 1–2 weeks to conclude whether the treat-
ment was successful or not [155].
11.3 Emphysematous pyelonephritis
Emphysematous pyelonephritis (EPN) is a severe necrotizing infection of the 
renal parenchyma and its surrounding tissues—resulting in the presence of gas in 
the renal parenchyma, collecting system or perinephric tissue—and is caused in 
70% of cases by Escherichia coli (isolated in cultures of urine or pus from patients 
with the condition) [156].
The clinical evolution of EPN when not recognized and treated immediately can 
be serious and pose a risk to the patient’s life. Another fact that should be mentioned 
is that up to 95% of the cases of EPN are underlyingly associated with uncontrolled 
diabetes mellitus [157, 158].
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In addition to the risk of developing EPN primarily, the risk of developing 
secondary to an obstruction of the urinary tract is considerably relevant, about 
25–40% can be considered as positive findings in EPN [159, 160].
The combination of percutaneous drainage (PCD) and medical management 
(MM) revealed a significant reduction in mortality rates [161, 162]. Thus, it is 
recommended that PCD be performed in patients with localized areas of gas and 
the presence of functional renal tissue. Another approach that can be used in 
association with treatment is emergency nephrectomy, classified as simple, radical 
or laparoscopic [163].
11.4 Renal abscess
Being caused by kidney stones, structural abnormality, history of urological 
surgery, trauma or any other cause of obstruction, renal abscess can also be related 
to pathogens [164]. The predominant organisms causing renal abscesses are Gram-
negative organisms, and the most common is Escherichia coli [165–167].
Among the various intra-abdominal abscesses, renal abscess is a rare entity, 
especially in children and accounts for a number of cases of “missed diagnoses” 
[166, 168].
With regard to the symptoms of pediatric patients, the presentation of fever, 
flank pain, with or without a palpable mass, has been established in the literature; 
increased leukocyte count and increased erythrocyte sedimentation rate [169].
Early diagnosis is a key factor in the management of these patients, which 
can be aided by Ultrasound (USG). Drainage of pus and appropriate antibiotic 
therapy is the gold standard for treatment, being able to treat a great amount of 
cases. Thereby, the most successful combination of antibiotics was ceftriaxone, 
being associated with amikacin. Cases that cannot be resolved by the conventional 
approach can be treated with surgery, such as nephrectomy. Thus, complications 
such as extension of the peritoneal cavity, skin or chest can be avoided [166, 167].
11.5 Perinephric abscess
Perinephric abscess results from perirenal fatty necrosis, usually a complica-
tion of urological infection (more than 75%) [170]. Most of these abscesses have 
Escherichia coli as the main responsible, about 51.4% [171]. Perinephric abscess, 
when more diffuse, is capable of affecting the renal capsule and also Gerota’s fascia 
[170]. Since the condition has an insidious onset of nonspecific protein symptoms, 
it is necessary for a clinical physician to maintain a high level of attention to avoid 
possible delay in diagnosis, since perinephric abscesses are associated with signifi-
cant morbidity and mortality [172].
11.6 Renal papillary necrosis
Renal papillary necrosis (NPN) is a condition defined as ischemic necrobiosis of 
the papilla in the kidney medulla. Among several etiological factors important for 
the involvement of papillary necrosis, pyelonephritis due to bacterial uropathogens 
such as E. coli is one of those mentioned in the literature [173].
In order to improve the prognosis of the disease and reduce morbidity, the ideal 
is that the diagnosis of the disease is as early as possible. In this sense, it is clear that 
the radiological image is able to offer an early diagnosis and guidance in relation to 
the immediate treatment of papillary necrosis, thus minimizing the decline in renal 
function [174].
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11.7 Prostatic abscess
Failure to respond to standard therapy for acute bacterial prostatitis can lead to 
complications, such as prostate abscess or fistula [175].
Acute bacterial prostatitis is a common and clinically important genitourinary 
disorder that has a higher incidence in patients with diabetes, cirrhosis and sup-
pressed immune system. Usually caused by an ascending infection, it can also be 
triggered by organisms that cause other common genitourinary infections that 
may also be responsible for acute bacterial prostatitis. Being introduced during 
transrectal prostate biopsy, the clinical presentation ranges from mild symptoms of 
the lower urinary tract to total sepsis, and Escherichia coli is one of the main bacteria 
related to the clinical picture.
Regarding the therapeutic approach, oral or intravenous antibiotics are most 
effective in curing the infection. In this sense, the progression to chronic bacte-
rial prostatitis is uncommon. It should be noted that special attention is needed 
in relation to immunosuppressed patients, whereas bacterial prostatitis in these 
patients may be caused by atypical infecting organisms and, therefore, may require 
additional therapies [176].
12. Prevention
It is already known that iron is an essential micronutrient for most bacteria and 
hosts, in this thought line, it is also known that there are relatively rare classical 
siderophilic pathogens that cause an increase in hepcidin in the body, responsible 
for the sequestration of iron for macrophages and enterocytes and, consequently 
hypoferremia [177–180]. So, current studies investigate if this mechanism used by 
the body against rare siderophilic bacteria, it also works for a wider set of bacteria. 
Results of these studies are shown to be positive, by demonstrating that excess 
iron allows rapid bacterial replication and spread, which means a susceptibility to 
infection caused by E. coli and that hepcidin is essential to protect against infections 
caused by Escherichia coli. [181, 182]. Thus, the use of hepcidin agonists promises to 
be an effective early intervention in patients with infections and dysregulated iron 
metabolism to avoid complications.
With regard to urinary tract infection, an effective preventive measure is the 
characterization and correction of the underlying genitourinary abnormalities that 
promote the infection. Another alternative mentioned in the literature is the future 
development of catheters whose material limits the growth of biofilm [109].
13. Conclusion
Early symptom recognition, followed by appropriate investigations, accurate 
diagnosis and early goal-directed therapy, is essential to improve results. Patient 
management includes an interprofessional team approach, with microbiologists, 
radiologists, surgeons and intensive care physicians [109].
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